AVISE SLE Prognostic
The Specialized SLE Prognostic Test for Rheumatologists
AVISE® SLE Prognostic is a 10-marker panel developed to help assess a patient’s potential risk for Thrombosis, Cardiovascular events, Lupus Nephritis and Neuropsychiatric Lupus. The test includes the following assays:
Peer reviewed articles:
Akhter E, et al. Anti-C1q antibodies have higher correlation with fl ares of lupus nephritis than other serum markers. Lupus. 2011.
Orbai A-M, et al. Anti-C1q Antibodies in Systemic Lupus Erythematosu. Lupus. 2015.
Akhter E, et al. Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus. Journal of Rheumatism. 2013
View Complete References